SCHEMBL3786516

SCHEMBL3786516

Nc1cccc(OCc2ccccc2)c1-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 1/20 0.56
MAPT P10636 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
MAPK1 P28482 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
LTA4H P09960 1/20 0.51
MAPK14 Q16539 1/20 0.51
DHFR P00374 1/20 0.48
DCPS Q96C86 1/20 0.47
HTR1A P08908 1/20 0.46
DRD2 P14416 1/20 0.46
KDM1A O60341 2/20 0.46
MAOB P27338 3/20 0.45
LIPE Q05469 1/20 0.45
GAA P10253 1/20 0.44
MAOA P21397 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PTGER1 P34995 2/20 0.43
PTGER4 P35408 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3790369 0.92 MAPT (0.53) APPMAPTL3MBTL1MAPK1TDP1
SCHEMBL3792778 0.89 MAOB (0.54) APPMAPTL3MBTL1MAPK1TDP1
SCHEMBL3792054 0.85 MAPT (0.51) APPMAPTL3MBTL1MAPK1TDP1
SCHEMBL30719053 0.83 MAPT (0.62) MAPTL3MBTL1MAPK1TDP1LTA4H
SCHEMBL292275 0.81 APP (0.72) APPMAPTL3MBTL1MAPK1TDP1
SCHEMBL8216313 0.81 MAPT (0.69) MAPTL3MBTL1MAPK1TDP1LTA4H
SCHEMBL23294813 0.81 APP (0.62) APPMAPTL3MBTL1MAPK1TDP1
SCHEMBL3793754 0.81 ALDH1A1 (0.63) MAPTL3MBTL1MAPK1TDP1GAA
SCHEMBL29587072 0.81 APP (0.62) APPMAPTL3MBTL1MAPK1TDP1
SCHEMBL18075739 0.81 MAPT (0.55) MAPTL3MBTL1MAPK1TDP1LTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 APP 2554/4885MAPT 3312/4885L3MBTL1 3838/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.